Okyo Pharma Limited ADR (OKYO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3500 +0.0900 (+7.14%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3900 +0.0400 (+2.96%) 19:54 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2024 | 03-2024 | 03-2023 | 09-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,098 | -16,803 | -13,284 | -5,365 | -6,218 |
| Depreciation Amortization | 1 | 4 | 4 | 2 | 2 |
| Accounts payable and accrued liabilities | 2,545 | N/A | N/A | N/A | N/A |
| Other Working Capital | 2,427 | 2,669 | 3,946 | 1,154 | -1,024 |
| Other Operating Activity | -1,117 | 4,639 | 1,639 | 789 | 1,772 |
| Operating Cash Flow | $-241 | $-9,491 | $-7,695 | $-3,420 | $-5,468 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | -6 | -3 | -2 |
| Investing Cash Flow | $N/A | $0 | $-6 | $-3 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 550 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 2 | 6,209 | 9,323 | 1,748 | 2,153 |
| Financing Cash Flow | $552 | $6,209 | $9,323 | $1,748 | $2,153 |
| Exchange Rate Effect | -150 | 64 | -278 | N/A | -872 |
| Beginning Cash Position | 827 | 4,045 | 2,701 | 2,421 | 6,889 |
| End Cash Position | 987 | 827 | 4,045 | 746 | 2,701 |
| Net Cash Flow | $160 | $-3,219 | $1,345 | $-1,675 | $-4,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -241 | -9,491 | -7,695 | -3,420 | -5,468 |
| Free Cash Flow | -241 | -9,491 | -7,695 | -3,420 | -5,468 |